Searching journal content for articles similar to Thomas et al. 23 (10): 797.

Displaying results 1-10 of 1073
For checked items
  1. Research:
    • Shuk-Mei Ho,
    • Rahul Rao,
    • Sarah To,
    • Emma Schoch,
    • and Pheruza Tarapore
    Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer Endocr Relat Cancer 24 (2) 83-96, doi:10.1530/ERC-16-0175 first published on 20 December 2016
    ...is being replaced by these compounds in BPA-free consumer products. We have previously shown that chronic and developmental exposure to BPA is associated with increased prostate cancer (PCa) risk in human and animal models. Here, we examine whether exposure of PCa cells (LNCaP, C4-2) to low-dose BPA...
  2. Review:
    • Takuma Uo,
    • Stephen R Plymate,
    • and Cynthia C Sprenger
    Allosteric alterations in the androgen receptor and activity in prostate cancer Endocr Relat Cancer 24 (9) R335-R348, doi:10.1530/ERC-17-0108
    ... England Journal of Medicine 371 1028–1038. (doi:10.1056/ NEJMoa1315815) Antonarakis ES, Armstrong AJ, Dehm SM & Luo J 2016 Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting. Prostate Cancer and Prostatic Diseases 19 231–241. (doi:10.1038/pcan.2016.17) Asangani IA...
  3. Research:
    • Zhu Wang,
    • Dinglan Wu,
    • Chi-Fai Ng,
    • Jeremy Yuen-Chun Teoh,
    • Shan Yu,
    • Yuliang Wang,
    • and Franky Leung Chan
    Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer Endocr Relat Cancer ERC-17-0280, doi:10.1530/ERC-17-0280 first published on 17 October 2017
    ...of genes involved in a board range of 28 developmental, reproductive, metabolic and immunological programs. Given the significant 29 importance of androgen receptor and a few known NRs in the progression of prostate cancer, 30 we surveyed the expression profiles of the entire NR superfamily in three...
  4. Review:
    • Gido Snaterse,
    • Jenny A Visser,
    • Wiebke Arlt,
    • and Johannes Hofland
    Circulating steroid hormone variations throughout different stages of prostate cancer Endocr Relat Cancer 24 (11) R403-R420, doi:10.1530/ERC-17-0155 first published on 18 September 2017
    .... The androgen receptor is the primary driver of tumor cell proliferation and is activated by the androgens testosterone and 5α-dihydrotestosterone. Inhibition of this pathway through medical or surgical castration improves survival in the majority of advanced prostate cancer patients. However, conversion...
  5. Thematic Review:
    • Melissa Gamat and
    • Douglas G McNeel
    Androgen deprivation and immunotherapy for the treatment of prostate cancer Endocr Relat Cancer 24 (12) T297-T310, doi:10.1530/ERC-17-0145 first published on 16 August 2017
    ...treatment for prostate cancer, however, are sometimes used in combination with other therapies. Many other AR-targeted agents are in development for the treatment of advanced, metastatic CRPC and include androgen receptor degrading agents such as galeterone, T299Thematic Review M Gamat and D G Mc...
  6. Review:
    • Jennifer Munkley
    Glycosylation is a global target for androgen control in prostate cancer cells Endocr Relat Cancer 24 (3) R49-R64, doi:10.1530/ERC-16-0569 first published on 3 February 2017
    ...with prostate cancer. Keywords androgen receptor glycosylation prostate cancer glycans Introduction The prostate gland is principally responsible for secreting fluid, which nourishes and protects sperm during reproduction. Both the development of the prostate gland and maintenance of these secretory functions...
  7. Research:
    • Tianzhu Zang,
    • Mary-Ellen Taplin,
    • Daniel Tamae,
    • Wanling Xie,
    • Clementina Mesaros,
    • Zhenwei Zhang,
    • Glenn Bubley,
    • Bruce Montgomery,
    • Steven P Balk,
    • Elahe A Mostaghel,
    • Ian A Blair,
    • and Trevor M Penning
    Testicular vs adrenal sources of hydroxy-androgens in prostate cancer Endocr Relat Cancer 24 (8) 393-404, doi:10.1530/ERC-17-0107 first published on 29 June 2017
    ...prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer. European Urology 38 706–713. (doi:10.1159/000020366) Shafi AA, Yen AE & Weigel NL 2013 Androgen receptors...
  8. Review:
    • Tesa M Severson and
    • Wilbert Zwart
    A review of estrogen receptor/androgen receptor genomics in male breast cancer Endocr Relat Cancer 24 (3) R27-R34, doi:10.1530/ERC-16-0225 first published on 6 January 2017
    .... ( doi:10.1016/j.ejso.2005.09.013 ) ↵ Nevedomskaya E , Stelloo S , van der Poel HG , de Jong J , Wessels LFA , Bergman AM & Zwart W 2016 Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer . Genomics Data 7 124 – 126 . ( doi:10.1016/j.gdata.2015.12.020 ) ↵ Nilsson C...
  9. Review:
    • Gianmarco Leone,
    • Marcello Tucci,
    • Consuelo Buttigliero,
    • Clizia Zichi,
    • Daniele Pignataro,
    • Paolo Bironzo,
    • Francesca Vignani,
    • Giorgio Scagliotti,
    • and Massimo Di Maio
    Anti-androgen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer ERC-17-0355, doi:10.1530/ERC-17-0355 first published on 28 September 2017
    ...(AA) in bone metastatic castration resistant prostate cancer (mCRPC). J Clin Oncol 377 32:5s, 2014 (Suppl; Abstr 5000) 32. 378 Page 17 of 25 18 Fenton MA, Shuster TD, Fertig AM, Taplin ME, Kolvenbag G, Bubley GJ & Balk SP 1997 Functional 379 characterization of mutant androgen receptors from androgen...
  10. Review:
    • Jennifer L Bishop,
    • Alastair Davies,
    • Kirsi Ketola,
    • and Amina Zoubeidi
    Regulation of tumor cell plasticity by the androgen receptor in prostate cancer Endocr Relat Cancer 22 (3) R165-R182, doi:10.1530/ERC-15-0137 first published on 1 May 2015
    ...pnd bia r, B Abstract prostate " androgen receptor " endocrine therapy resistance Introduction treated with androgen deprivation therapy (ADT), a key remains incurable because resistance rapidly emerges via and/or alternative adaptive 2013). Tumor cell plasticity ivation may play a principal...
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most